AU2002321903A1 - Molecular interactions in cells - Google Patents
Molecular interactions in cellsInfo
- Publication number
- AU2002321903A1 AU2002321903A1 AU2002321903A AU2002321903A AU2002321903A1 AU 2002321903 A1 AU2002321903 A1 AU 2002321903A1 AU 2002321903 A AU2002321903 A AU 2002321903A AU 2002321903 A AU2002321903 A AU 2002321903A AU 2002321903 A1 AU2002321903 A1 AU 2002321903A1
- Authority
- AU
- Australia
- Prior art keywords
- cells
- molecular interactions
- interactions
- molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000004001 molecular interaction Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003291558A AU2003291558B2 (en) | 2001-08-03 | 2003-11-14 | Molecular interactions in neurons |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30984101P | 2001-08-03 | 2001-08-03 | |
| US60/309,841 | 2001-08-03 | ||
| US36006102P | 2002-02-25 | 2002-02-25 | |
| US60/360,061 | 2002-02-25 | ||
| PCT/US2002/024655 WO2003014303A2 (fr) | 2001-08-03 | 2002-08-02 | Interactions moleculaires dans les cellules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003291558A Division AU2003291558B2 (en) | 2001-08-03 | 2003-11-14 | Molecular interactions in neurons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002321903A1 true AU2002321903A1 (en) | 2003-02-24 |
Family
ID=26977039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002321903A Abandoned AU2002321903A1 (en) | 2001-08-03 | 2002-08-02 | Molecular interactions in cells |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1443951A4 (fr) |
| AU (1) | AU2002321903A1 (fr) |
| CA (1) | CA2457424A1 (fr) |
| WO (1) | WO2003014303A2 (fr) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6942981B1 (en) | 1999-05-14 | 2005-09-13 | Arbor Vita Corporation | Method of determining interactions with PDZ-domain polypeptides |
| WO2002058450A2 (fr) | 2000-12-22 | 2002-08-01 | Dana-Faber Cancer Institute, Inc. | Regulation de la proliferation cellulaire par muc1 |
| AU2003291558B2 (en) * | 2001-08-03 | 2009-08-13 | Arbor Vita Corporation | Molecular interactions in neurons |
| WO2004045535A2 (fr) * | 2002-11-14 | 2004-06-03 | Arbor Vita Corporation | Interactions moleculaires dans des neurones |
| DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| WO2004076646A2 (fr) * | 2003-02-27 | 2004-09-10 | Arbor Vita Corporation | Methodes et compositions destinees a traiter le cancer du col uterin |
| KR20060037244A (ko) * | 2003-05-02 | 2006-05-03 | 스코티쉬 바이오메디컬 리미티드 | 소형 GTPase들의 Rap과에 속하는 단백질에 대한구아닌 염기 교환 인자의 조절 |
| WO2004108142A2 (fr) * | 2003-06-06 | 2004-12-16 | The University Of Manchester | Traitement d'etats lies au vieillissement |
| EP1995256A1 (fr) * | 2003-07-30 | 2008-11-26 | University of Pittsburgh of the Commonwealth System of Higher Education | Agonistes d'épitope de cellule T EPHA2 T et utilisations correspondantes |
| US8129506B2 (en) | 2003-10-24 | 2012-03-06 | Genzyme Corporation | Modulation of the interaction of MUC1 with MUC1 ligands |
| EP1708745B1 (fr) | 2003-12-23 | 2012-04-18 | Arbor Vita Corporation | Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation |
| US7858322B2 (en) | 2003-12-23 | 2010-12-28 | Nono, Inc. | Method of determining inhibition of binding to TRPM7 protein |
| DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| CN101291683B (zh) * | 2004-11-24 | 2011-08-17 | 纽普罗研究有限公司 | 治疗疾病的方法和组合物 |
| EP2289535B8 (fr) | 2004-12-21 | 2018-08-08 | MUSC Foundation for Research Development | Compositions et procédés pour la promotion de la cicatrisation de plaies et de la régénération de tissus |
| US9408381B2 (en) | 2004-12-21 | 2016-08-09 | Musc Foundation For Research Development | Alpha Connexin c-Terminal (ACT) peptides for use in transplant |
| DE102005022182A1 (de) * | 2005-05-09 | 2006-11-16 | Combinature Biopharm Ag | Modulatoren der PDZ-Domäne |
| JP2009503439A (ja) * | 2005-07-01 | 2009-01-29 | アルボー ビータ コーポレーション | ウイルス感染および細菌感染の診断および処置のための方法および組成物 |
| EP1790664A1 (fr) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Anticorps monoclonaux contre claudin-18 pour le traitement du cancer |
| US8633160B2 (en) | 2005-12-30 | 2014-01-21 | Nono Inc. | Small molecule inhibitors of PDZ interactions |
| US7972870B2 (en) | 2007-02-02 | 2011-07-05 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3 |
| WO2008097844A2 (fr) | 2007-02-02 | 2008-08-14 | Dana -Farber Cancer Institute, Inc. | Méthodes et compositions associées à la régulation de l'apoptose par des protéines muc1 et des protéines pro-apoptotiques contenant seulement le domaine bh3 |
| PL2320927T3 (pl) * | 2008-07-09 | 2016-02-29 | Univ Copenhagen | Modyfikowane peptydy jako potencjalne inhibitory w reakcjach receptorów PSD 95 i NMD |
| RU2657535C2 (ru) | 2012-03-01 | 2018-06-14 | Ферстстринг Рисерч, Инк. | Гели для местного применения, содержащие с-концевые пептиды альфа-коннексина (act) |
| WO2013167153A1 (fr) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Anticorps utiles dans le diagnostic du cancer |
| US20160166637A1 (en) * | 2013-08-02 | 2016-06-16 | Virginia Tech Intellectual Properties, Inc. | Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction |
| EP3074030A4 (fr) * | 2013-11-26 | 2017-08-16 | Trustees of Dartmouth College | Procédé permettant d'atténuer ou de soulager des déficits synaptiques et cognitifs |
| JP6683686B2 (ja) | 2014-08-22 | 2020-04-22 | オークランド ユニサービシーズ リミティド | チャネル調節剤 |
| EA039314B1 (ru) | 2017-07-05 | 2022-01-12 | Биоселз (Бейдзин) Биотек Ко., Лтд. | Фармацевтически приемлемые соли полипептидов и их применение |
| CA3196342A1 (fr) | 2020-10-22 | 2022-04-28 | Gautam Ghatnekar | Formulations peptidiques et utilisations ophtalmiques associees |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976819A (en) * | 1995-11-21 | 1999-11-02 | National Jewish Medical And Research Center | Product and process to regulate actin polymerization in T lymphocytes |
| US6911526B2 (en) * | 1996-07-22 | 2005-06-28 | The Trustees Of Columbia University In The City Of New York | Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| WO2000031124A2 (fr) * | 1998-11-20 | 2000-06-02 | Mount Sinai Hospital | Peptides modulant l'interaction des ephrines de classe b avec les domaines pdz |
| EP1178817A2 (fr) * | 1999-05-14 | 2002-02-13 | Arbor Vita Corporation | Interactions moleculaires dans les cellules hematopoietiques |
-
2002
- 2002-08-02 AU AU2002321903A patent/AU2002321903A1/en not_active Abandoned
- 2002-08-02 EP EP02756934A patent/EP1443951A4/fr not_active Withdrawn
- 2002-08-02 CA CA002457424A patent/CA2457424A1/fr not_active Abandoned
- 2002-08-02 WO PCT/US2002/024655 patent/WO2003014303A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1443951A4 (fr) | 2006-05-03 |
| CA2457424A1 (fr) | 2003-02-20 |
| EP1443951A2 (fr) | 2004-08-11 |
| WO2003014303A2 (fr) | 2003-02-20 |
| WO2003014303A3 (fr) | 2003-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002321903A1 (en) | Molecular interactions in cells | |
| AU2002239336A1 (en) | Molecular interactions in hematopoietic cells | |
| AU2001270819A1 (en) | Polymer electrolyte | |
| AU2001258394A1 (en) | Weather-resistant polymer blends | |
| AU2003223244A1 (en) | Molecular switches and methods for making and using the same | |
| AUPQ520600A0 (en) | Improvements in electrolysis cells | |
| AUPS198302A0 (en) | Improvements in bowsprits | |
| AU2002215354A1 (en) | Molecular interactions in hematopoietic cells | |
| AU2002240892A1 (en) | Protein-protein interactions in adipocyte cells | |
| AU2002343025A1 (en) | Improvements in footwear | |
| AU2002301358A1 (en) | Improvements in Transmissometers | |
| AU2002301354A1 (en) | Improvements in Transmissometers | |
| AU2003234023A1 (en) | Improvements in loudspeakers | |
| AU2001286809A1 (en) | Genes expressed in the cell cycle | |
| AU5269800A (en) | Molecular interactions in allergy cells | |
| AUPR968801A0 (en) | Improvements in enzyme stability | |
| AU2002350591A1 (en) | Electrochemical half cell | |
| AU2002256468A1 (en) | Molecular memory cell | |
| AU2002343038A1 (en) | Improvements in keyboards | |
| AU2002363030A1 (en) | Electrochemical half cell | |
| AU2002256572A1 (en) | Improvements in enzyme stability | |
| AUPR968901A0 (en) | Improvements in enzyme stability | |
| AUPR553201A0 (en) | Improvements in enzyme stability | |
| AUPR808601A0 (en) | Improvements in levels | |
| AUPQ519700A0 (en) | Elecrolytic cell |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |